Company Filing History:
Years Active: 2008-2010
Title: Kimihasa Ichikawa: Innovator in Cancer Detection
Introduction
Kimihasa Ichikawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, Ichikawa is dedicated to advancing methods for cancer detection and treatment.
Latest Patents
Ichikawa's latest patents focus on the development of antibodies against tumor-specific antigens. One of his notable inventions relates to a method of detecting cancer using an oncogene. This method includes screening for active compounds that can be useful in treating and preventing cancer. Specifically, it provides a way to detect cancer based on the expression of the human oculospanin gene as a marker. Additionally, it includes a pharmaceutical composition containing an antibody that can specifically recognize human oculospanin and exhibit cytotoxic activity against cancer cells.
Career Highlights
Ichikawa is currently associated with Sankyo Company, Limited, where he continues to work on groundbreaking research in oncology. His work has the potential to significantly impact cancer diagnostics and therapeutics.
Collaborations
Ichikawa collaborates with esteemed colleagues such as Shu Takahashi and Toshinori Agatsuma. Their combined expertise enhances the research efforts in developing effective cancer treatments.
Conclusion
Kimihasa Ichikawa's contributions to cancer detection and treatment through his innovative patents highlight his role as a key figure in medical research. His work continues to inspire advancements in the fight against cancer.